Stock Based Compensation - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands |
9 Months Ended | ||
---|---|---|---|
Jan. 01, 2023 |
Sep. 30, 2023 |
Sep. 30, 2022 |
|
Defined Benefit Plan Disclosure [Line Items] | |||
Proceeds from exercise of stock options | $ 0 | $ 797 | |
Number of options outstanding, Granted | 61,446 | 0 | |
weighted-average grant date fair value of options granted | $ 2.77 | ||
Restricted Stock Units (RSUs) | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Unrecognized stock-based compensation expense | $ 25,180 | ||
Unrecognized stock-based compensation expense, weighted-average recognition period | 2 years 2 months 23 days | ||
2021 Equity Incentive Plan | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Number of shares issued under share-based payment arrangement | 897,996 | 490,623 | |
2021 ESPP | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Number of shares issued under share-based payment arrangement | 179,599 | 603,349 |
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Amount of cost not yet recognized for nonvested award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of cash inflow from exercise of option under share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of shares issued under share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|